Clinical Trial Update: Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy of Å6 in ovarian cancer patients who have completed first-line chemotherapy and show rising CA-125; the study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Carcinoma

Drugs mentioned

• Å6

Snippet

Sponsor: Ångstrom Pharmaceuticals | Conditions: Ovarian Cancer, Primary Peritoneal Carcinoma | Phase 2 | Status: COMPLETED